Figure 4: Treatment of diabetic obese Golden Syrian hamsters with microencapsulated L.f. 11976 resulted in a non-significant reduction in (A) serum glucose levels following 10 weeks of treatment, but showed a significant reduction in (B) serum insulin levels (**p < 0.01). (C) Insulin resistance was quantified using Homeostasis Model Assessment (HOMA-IR). The treated group showed HOMA-IR values significantly lower than untreated control animals (**p < 0.01). Data represents the mean ± SEM (n = 12).